FPM Annual Symposium 2022
Can we? Should we?
Fostering trust through ethical practice
Thursday 3 November 2022
Professor Raanan Gillon
Emeritus Professor of Medical Ethics at Imperial College London
Raanan Gillon is a hybrid of retired NHS GP and academic medical ethicist. He is Emeritus Professor of Medical Ethics at Imperial College London, where he still does a little teaching and continues to direct its five day intensive course in medical ethics, aimed primarily at practising doctors, which he started in 1983. He is past chairman and now honorary President of the Institute of Medical Ethics and a past President of the British Medical Association. He edited the Journal of Medical Ethics for 20 years, has published extensively on medical ethics and his elderly book ‘Philosophical Medical Ethics’ is in its 13th print. He enthusiastically advocates the ‘four principles approach’ to medical ethics.
Professor Ben Goldacre
Director of Bennett Institute for Applied Data Science
Ben is a doctor, academic, writer, and broadcaster. He trained in medicine at Oxford and UCL, in psychiatry at the Maudsley, and in epidemiology at LSHTM. His academic and policy work is in informatics, epidemiology and evidence based medicine, where he works on various problems including variation in care, better uses of routinely collected electronic health data, evidence-based social policy, access to clinical trial data, efficient trial design, and retracted papers.
Ben runs the Bennett Institute for Applied Data Science. This is a multidisciplinary team of academics, clinicians and software developers, all pooling skills and knowledge to turn large datasets into tools and services as well as pure academic research papers.
Professor Chris Whitty FFPM (Hon)
Chief Medical Officer for England, Chief Medical Adviser to the UK Government
Professor Chris Whitty is Chief Medical Officer (CMO) for England, the UK government’s Chief Medical Adviser and head of the public health profession. He represents the UK on the Executive Board of the World Health Organization.
Chris is a practising NHS Consultant Physician at University College London Hospitals (UCLH) and the Hospital for Tropical Diseases, and Gresham Professor of Physic at Gresham College. He is also an epidemiologist and has undertaken research and worked as a doctor in the UK, Africa and Asia.
Dr Nick Broughton MFPM
Educator and Founding Partner, Ethos Ethics and Compliance Ltd
Nick is a Founding Partner of Ethos, a company specialising in education and behaviour change in the field of pharmaceutical ethics and compliance. He is a pharmaceutical physician with over 20 years’ experience within the industry, including senior medical roles in UK and European Medical and Regulatory Affairs for AstraZeneca and Celgene. He is actively involved in advising large and small pharmaceutical companies on their promotional and other activities across both traditional and digital channels.
Nick has post graduate qualifications in medical ethics and law from Keele University, UK. The educational programmes he has developed draw heavily on theories of medical ethics and their practical application in business decision-making and commercial campaigns.
Dr Alex McKeown
Deputy Director, UK Pandemic Ethics Accelerator/Research Fellow – Department of Psychiatry, University of Oxford
Alex McKeown is a Research Fellow with the Neuroscience, Ethics & Society group and Wellcome Centre for Ethics and the Humanities at the University of Oxford. He was Deputy Director of the UK Pandemic Ethics Accelerator, which provided rapid ethics analysis to challenges arising during the COVID-19 pandemic. Alex’s research interests range widely across philosophical and ethical questions in medicine, neuroscience, psychiatry, mental health, and public health, among others. He holds a PhD in Bioethics from the University of Bristol, and prior to returning to academia for his PhD he spent several years working in patient advocacy and policy research.
PhD researcher, Centre for Technomoral Futures, University of Edinburgh
Jamie is a PhD researcher in the University of Edinburgh’s Centre for Technmoral Futures, working on the project AI and Ethical Decision-Making in a Resource-Limited Health Care Environment. In addition to his doctoral research, he was a researcher on the UK Pandemic Ethics Accelerator until July 2022, working on its public values, transparency and governance workstream. Prior to his PhD he worked as a Research Associate in the Division of Medical Ethics at NYU Langone. He earned an MA in Bioethics at NYU as a Fulbright Postgraduate Scholar, and gained his undergraduate degree in Philosophy at Pembroke College, Cambridge.
Professor Carol Brayne CBE
Co-Director of Cambridge Public Health; Professor of Public Health Medicine
Carol is a Professor of Public Health Medicine and Co-Director of Cambridge Public Health Interdisciplinary Centre at the University of Cambridge. She is a medically qualified epidemiologist and public health academic. Her main research has been longitudinal studies of older people following changes over time with a public health perspective and focus on the brain. She is lead principal investigator in the MRC Cognitive Function and Ageing Studies and other population based studies and has played a lead role in teaching and training in epidemiology and public health at Cambridge University. She is a Fellow of the Academy of Medical Sciences and an NIHR Senior Investigator Emeritus.
Dr Susan Tansey FFPM
Independent Consultant Pharmaceutical Physician, Member of the Nuffield Council on Bioethics
Susan is an independent Consultant Pharmaceutical Physician working with small and medium sized companies in the pharmaceutical industry. She trained in paediatrics and neonatology in the NHS but having an interest in clinical research she joined the pharmaceutical industry in 1998. Since then she has been involved in the clinical development of new medicines and vaccines in several therapeutic areas with a focus on rare diseases and paediatrics. Susan has worked in both pharmaceutical companies and contract research organisations and held the position of Associate Director for Industry at the UK’s Medicines for Children Network (MCRN) from 2011 to 2015.
Associate Director, Nuffield Council on Bioethics
Catherine is Associate Director at the Nuffield Council on Bioethics, where she leads a programme of policy-focused projects and the Council’s horizon scanning work. Her work has covered topics including the ethics of genomic healthcare and screening, conflict in the care of critically ill children, and the public health response to COVID-19. In 2020-21, Catherine spent 15 months on secondment at the UK National Screening Committee as an ethics and stakeholder engagement consultant. Prior to working at the Nuffield Council, Catherine worked at the Royal Society of Biology and in the pharmaceutical marketing sector. She has a degree in Biology from the University of Bristol.
Trishna Bharadia MFPM (Hon)
Visiting Lecturer on Patient Engagement, King’s College London
Trishna is a multi-award winning health advocate and patient engagement consultant, working with multiple stakeholders, including pharma, to embed the patient voice into medicines development and the healthcare journey. She’s a patron/ambassador for several health- and disability-related organisations, including MS Society and ADD International, the Patient Engagement Editor for the Drug Information Association’s Global Forum magazine, and a visiting lecturer on patient engagement at King’s College London university. Media work includes the BBC (television/radio), Sky News, New York Times, Huffington Post, Which?, Medscape, WebMD and various pharma industry publications. Awards include a Points of Light from 10 Downing Street for her work with patient communities and she is an Honorary Member of FPM.
Dr Lode Dewulf
Carer, Patient, Visiting Lecturer and Independent Consultant
Lode is a former Fellow of the Faculty of Pharmaceutical Medicine, a past Board Member, and a former executive leader in industry. His current roles include: certified independent board director, consultant, coach, charity volunteer, and also those of patient and carer. He currently continues with passion some projects in patient affairs, medical affairs, personal development and business strategy.
After his medical training and GP practice he joined the pharmaceutical industry in 1989. He was the first Belgian industry physician to obtain the Diploma in Pharmaceutical Medicine and to be officially recognised as physician-specialist in pharmaceutical medicine in Belgium. His rich and varied full-time industry career spanned over 30 years and several functions, including Medical Affairs, Drug Safety, and Health Economics.
Dr Ian Hudson OBE, FFPM
Senior Advisor, Integrated Development, Gates Foundation
Ian practiced as a paediatrician before working in research and development at SmithKline Beecham for 11 years. Subsequently, in 2001, he joined the MHRA as Director of Licensing and was the UK delegate to EMA’s scientific committee, CHMP, latterly its Vice Chair. In 2013 Dr Hudson became CEO of the MHRA, also a member of the EMA management Board and part of the Heads of Medicines Agencies Management Group. He was also Chair of the International Coalition of Medicines Regulatory Authorities between 2016 and 2019. He retired from the MHRA in September 2019 and then joined the Bill and Melinda Gates Foundation as Senior Advisor, Integrated Development.
Dr Amit Aggarwal
Executive Director for Medical Affairs at the ABPI
Amit has over 14 years experience in the pharmaceutical industry, most recently at LEO Pharma as Medical Director for the UK and Ireland. Prior to that he spent over a decade at Bayer where he held various roles including pharmacovigilance, Global medical affairs, and latterly as Director of Medical Affairs UK for General Medicine.
His background is as a medic, spending five years working clinically in the NHS, mainly in secondary care. Amit has worked on both innovative and established product launches, spanning a range of therapy areas in the UK and globally.
Amit holds an MA in Neuroscience from the University of Cambridge, and an MBBS from Guy’s, King’s & St Thomas’ School of Medicine.
Dr Alison Cave
Chief Safety Officer, Medicines and Healthcare products Regulatory Agency
Alison joined the Medicines and Healthcare products Regulatory Agency (MHRA) in July 2021 as the Chief Safety Officer with responsibility for the safety of medicines and devices in the UK. She holds a BSc Honours degree and PhD from the University of London and has significant academic research and regulatory experience, the latter at both the European Medicines Agency (EMA) and MHRA. Previously she was Head of Cellular, Developmental and Physiological Sciences at the Wellcome Trust and most recently an Industrial Strategy Challenge Fund Director at UK Research and Innovation.
Dr Sebastian Grant
Winner of the Stonier Prize 2022
Dr Grant is a former Anaesthetics trainee who has recently moved into pharmaceutical medicine. Patient safety and communication have always areas of interest for him, with these interests have been developed further after being involved in clinical research as both a physician and now working for a trial sponsor. During his lecture, Dr Grant will highlight some of the challenges facing communication in paediatric studies and how these lessons could be extrapolated to engender greater trust in research as a whole.
Chief Executive of the Science Media Centre
Fiona is the chief executive and founding director of the Science Media Centre, which, since it was established in 2002, has become an indispensable resource for science journalists. She a has a degree in journalism and many years of experience working in media relations for high profile national organisations. Her career includes stints working for, amongst others, the Equal Opportunities Committee, the National Council for One Parent Families, and CAFOD (a leading aid agency).Fiona is also the author of Beyond the Hype: The inside story of science’s biggest media controversies.
Meet the event chairs
Dr Neil Snowise FFPM
FPM Annual Symposium 2022 co-chair (morning)
Neil is an independent pharmaceutical physician and Visiting Senior Lecturer in Pharmaceutical Medicine at King’s College.
He has worked at GSK in a range of roles leading clinical trials in allergy and asthma. During this time, he completed an MSc in Pharmaceutical Medicine with Distinction at Surrey University.
Subsequently Neil was Medical Director at a smaller clinical development company before returning for a second stint at GSK in 2014, working in the Global Respiratory Franchise, latterly medical lead for a Real World study in COPD, until 2019.
Prior to joining the pharmaceutical industry, he was senior partner in a GP Practice in Bath and Lecturer in General Practice at Bath University.
Dr Hosnieh Fathi FFPM
FPM Annual Symposium 2022 co-chair (afternoon)
Hosnieh is a clinical development expert with strategic intellect and a real-life patient/clinician-oriented mindset. She has qualifications from Medical School, Business School, School of Public Health, as well as PMST through FPM.
Her career in pharma started in a small unit in an academic setting, working as a clinical research fellow and investigator for early phase and pivotal studies. After completing my training in Internal Medicine officially moved to R&D in industry in 2011. As a Fellow of FPM, she has supported FPM in different capacities such as Educational Supervisor, General Medical Council Appraiser, and Training Ambassador for FPM.
Dr Sheuli Porkess FFPM
Sheuli is Vice-President of the Faculty of Pharmaceutical Medicine and the Director of Actaros Consultancy, a consultancy focussing on Medical Affairs and Life Science Policy.
Sheuli has expertise in medicine development, medical affairs and research policy within the UK and internationally. Her career has involved work on the ethical framework within the pharmaceutical industry including appropriate prescribing, transparency, clinical research, COVID and the 2021 ABPI Code of Practice. Sheuli was a member of the Advisory Group for the UKRI funded UK Pandemic Ethics Accelerator.
Sheuli is a Fellow of the Faculty of Pharmaceutical Medicine in the UK, Fellow of the Royal College of Physicians and a Global Fellow in Medicine Development with IFAPP and holds other advisory roles.
Dr David Gillen FFPM
Chief Medical Officer, Norgine
David qualified in Medicine, Physiology and Clinical Pharmacology from St. Mary’s Hospital (Imperial College of Science, Technology and Medicine) in 1992. He retained his interest in Pharmaceutical Medicine during his postgraduate training in Cardiology and General Medicine and joined Pfizer Global Research and Development Sandwich in 1999, his first of many roles at Pfizer.
After several years with Pfizer David went on to work at Gilead Sciences, Celgene’s Pharmacovigilance System in Europe, and the International Division of Vertex Inc, before taking up his current role at Norgine BV.
David is an honorary visiting senior lecturer at Queens University Belfast and Kings College London.
Dr Mehrunisha Suleman
Director of Medical Ethics and Law Education, Ethox Centre, University of Oxford
Mehrunisha is Director of Medical Ethics and Law Education at the University of Oxford. She is a medically trained bioethicist and public health researcher, whose research experience spans healthcare systems analysis to empirical ethics evaluation. Her research interests intersect global health research ethics and clinical ethics particularly where religious and cultural views and values of patients, clinicians and researchers are pertinent. She has extensive outreach and engagement experience, including working with minority groups and diverse sectors across the UK and globally. She is a member of the Nuffield Council on Bioethics and UNESCO’s International Bioethics Committee.